Navigation Links
MyClyns(TM) Now Available in Single Units
Date:5/29/2008

UNION, Ky., May 29 /PRNewswire/ -- Union Springs Pharmaceuticals, LLC, announced today it will now offer MyClyns in individually wrapped single units. These new packages provide enhanced tamper-proof protection for each MyClyns unit and also afford customers greater purchasing flexibility. Each sealed package will contain one MyClyns unit and a label card with directions for use and other important product information.

Furthermore, cases of MyClyns will now contain twenty-four single units rather than the eight three-packs found in previous cases. However, three- packs will be available for a short time while inventory lasts.

"Based on the feedback we have received from our customers, we are now pleased to offer individually packaged units for our customers," said Joel Ivers, President of Union Springs Pharmaceuticals. He added, "Customers wanted an easy way to determine whether a unit had been opened and they wanted the convenience to purchase one unit at a time. We satisfied both of these requests with one packaging solution."

MyClyns contains a fast-acting solution with germ-killing action that is safe to use on all mucous membranes including the eyes, ears, nose, mouth, and on open wounds. MyClyns' convenient pen-like design allows first responders to protect themselves immediately after exposure to potentially harmful pathogens when other alternatives are not available. Significantly, MyClyns is the only product on the market that can be safely used on the face. MyClyns is intended for immediate use by emergency medical, police, fire, corrections, military, healthcare providers, homeland security, and others exposed to bodily fluids.

About MyClyns(TM)

MyClyns(TM) (a pen-like device) is the only convenient, non-alcohol, first response spray providing personal protection immediately after a potentially pathogenic exposure. MyClyns contains a fast-acting solution with germ- killing action that is safe to use on all mucous membranes, including the eyes, nose, ears, mouth and on open wounds. Independent laboratory tests show that the solution in MyClyns demonstrated a 99.99% reduction in HIV-1, Hepatitis C, MRSA, C-diff and many other pathogens. MyClyns allows personnel to protect themselves after a pathogenic exposure when complete post-exposure protocols are rarely available. Visit the MyClyns website at http://www.myclyns.com for more information.

About Union Springs Pharmaceuticals, LLC

Union Springs Pharmaceuticals, LLC (USP) specializes in providing innovative over-the-counter (OTC) products for the consumer and healthcare markets. USP licenses, acquires, develops, and commercializes innovative products and technologies that satisfy the unmet needs of healthcare professionals and consumers. Union Springs Pharmaceuticals can be found on the Internet at http://www.uspharma.com


'/>"/>
SOURCE Union Springs Pharmaceuticals, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. First Responders Acquire Revolutionary MyClyns(TM) Protective Spray
2. CYNACON / OCuSOFT(R) Announces OCuSOFT(R) Lid Scrub(TM) PLUS Now Available in CVS Pharmacies
3. AMITIZA 8 mcg now available to treat irritable bowel syndrome
4. New Treatment Guide for Eating Disorders Available to Healthcare Professionals
5. Real Time, Face-to-Face Doctor Visits Now Available Online
6. SILS Surgical Technique Now Available at MUMC
7. AMDL Teleconference Available on amdl.com at 5:00 p.m. EDT Today
8. Healthy Farms, Healthy Schools Grant Applications Available
9. Wyeths Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
10. Traditional Medicare Benefit Information Soon to be Available Online to Doctors and Hospitals through Blue Cross Blue Shield of Michigan Web Portal
11. Dr. Said Hakki, President of Iraqi Red Crescent Organization, in the United States and Available for Interviews May 12-16
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... ... of the Best Places to Work in the Research Triangle for 2017. , ... nominated, a company had to meet a threshold in employee participation--a percentage that ...
(Date:9/20/2017)... ... 2017 , ... Demand generation pioneer True Influence has announced ... The Marketing Tech Conference October 2–4, at the Hynes Convention Center in Boston, ... representing such thought-leading companies as JP Morgan Chase, GE Digital, and Dun & ...
(Date:9/20/2017)... ... ... In just a short time since going on sale on Wal-Mart Stores-owned ... trying the product for the first time, and others who had already been using ... Moore, MD, for everyone from athletes at risk from multiple concussions to elderly consumers ...
(Date:9/20/2017)... ... September 20, 2017 , ... Health & Safety Institute (HSI) ... HAZWOPER 8-, 24- and 40-Hour courses from now until November 30, 2017 to assist ... offering these discounted prices to all businesses and government agencies – whether or not ...
(Date:9/20/2017)... ... September 20, 2017 , ... Houston, Texas, investment firm ... Friday, September 8, and Monday, September 11, off work and rolled up their sleeves ... before heading to local homes to start the process of rebuilding. , CORDA founder ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... IRVING, Texas , Sept. 7, 2017 /PRNewswire/ ... molecular science focused on fulfilling the promise of ... that further validate the benefits of its molecular ... Each study utilized comprehensive genomic profiling plus (CGP+) ... each individual patient,s tumor on a molecular level, ...
(Date:9/6/2017)... ANTONIO , Sept. 6, 2017  Robert G. ... a Pinnacle Professional Member in recognition of his contributions ... Szewc serves as a Nephrologist at the practice of ... emergency medicine, kidney care and hypertension solutions. He has ... 20 years of career experience, as well as expertise ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: ... for galcanezumab and lasmiditan, two investigational treatments for migraine, ... (IHC) taking place Sept. 7-10 in Vancouver ... long-term data from an open-label study evaluating the safety ... and 240 mg) for the prevention of migraine. Galcanezumab ...
Breaking Medicine Technology: